Dulac Edward J III sold NTLA

July 22, 2026 · Form 4 insider transaction

Dulac Edward J III sold 8,111 shares of Intellia Therapeutics, Inc. at $11.25 per share, a transaction worth $91.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
8,111
Price
$11.25
Total value
$91.2K
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 22, 2026
Filing dateJuly 24, 2026
Shares owned after148,175
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on July 22, 2026, and does not represent a volitional trade by the Reporting Person.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.25 to $11.28, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 22, 2026 at each separate price.

View the original Form 4 on SEC EDGAR